Few studies have examined the impact of chronic kidney disease (CKD) on adverse cardiovascular outcomes and deaths in Asian populations. We evaluated the associations of CKD with cardiovascular disease (CVD) and all-cause mortality in a multi-ethnic Asian population.
Design
Prospective cohort study of 7098 individuals who participated in two independent population-based studies involving Malay adults (n = 3148) and a multi-ethnic cohort of Chinese, Malay and Indian adults (n = 3950).
Methods
CKD was assessed from CKD-EPI estimated glomerular filtration rate (eGFR) and urine albumin-to-creatinine ratio (UACR). Incident CVD (myocardial infarction, stroke and CVD mortality) and all-cause mortality were identified by linkage with national disease/death registries.
Results
Over a median follow-up of 4.3 years, 4.6% developed CVD and 6.1% died. Risks of both CVD and all-cause mortality increased with decreasing eGFR and increasing albuminuria (all p-trend <0.05). Adjusted hazard ratios (HR (95% confidence interval)) of CVD and all-cause mortality were: 1.54 (1.05–2.27) and 2.21 (1.67–2.92) comparing eGFR <45 vs ≥60; 2.81 (1.49–5.29) and 2.34 (1.28–4.28) comparing UACR ≥300 vs <30. The association between eGFR <60 and all-cause mortality was stronger among those with diabetes (p-interaction = 0.02). PAR of incident CVD was greater among those with UACR ≥300 (12.9%) and that of all-cause mortality greater among those with eGFR <45 (16.5%).
Conclusions
In multi-ethnic Asian adults, lower eGFR and higher albuminuria were independently associated with incident CVD and all-cause mortality. These findings extend previously reported similar associations in Western populations to Asians and emphasize the need for early detection of CKD and intervention to prevent adverse outcomes.
LiPKTChowKMMatsuoS. Asian Chronic Kidney Disease (CKD) Best Practice Recommendations – Positional Statements for Early Detection of CKD from Asian Forum for CKD Initiatives (AFCKDI). Nephrology (Carlton)2011; 16: 633–641.
2.
WildSRoglicGGreenA. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care2004; 27: 1047–1053.
3.
HerzogCAAsingerRWBergerAK. Cardiovascular disease in chronic kidney disease. A clinical update from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int2011; 80: 572–586.
4.
SarnakMJ. Cardiovascular complications in chronic kidney disease. Am J Kidney Dis2003; 41: 11–17.
5.
MahmoodiBKMatsushitaKWoodwardM. Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without hypertension: a meta-analysis. Lancet2012; 380: 1649–1661.
6.
FoxCSMatsushitaKWoodwardM. Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis. Lancet2012; 380: 1662–1673.
7.
ZhangRZhengLSunZ. Decreased glomerular filtration rate is associated with mortality and cardiovascular events in patients with hypertension: a prospective study. PLoS One2011; 6: e27359–e27359.
8.
IkedaAKontaTTakasakiS. In a non-diabetic Japanese population, the combination of macroalbuminuria and increased urine beta 2-microglobulin predicts a decline of renal function: the Takahata study. Nephrol Dial Transplant2009; 24: 841–847.
9.
WenCPChengTYTsaiMK. All-cause mortality attributable to chronic kidney disease: a prospective cohort study based on 462 293 adults in Taiwan. Lancet2008; 371: 2173–2182.
10.
NakayamaMMetokiHTerawakiH. Kidney dysfunction as a risk factor for first symptomatic stroke events in a general Japanese population-the Ohasama study. Nephrol Dial Transplant2007; 22: 1910–1915.
11.
WoodwardMZhangXBarziF. The effects of diabetes on the risks of major cardiovascular diseases and death in the Asia-Pacific region. Diabetes Care2003; 26: 360–366.
12.
KearneyPMWheltonMReynoldsK. Global burden of hypertension: analysis of worldwide data. Lancet2005; 365: 217–223.
13.
SabanayagamCWongTYLimSC. Ethnic disparities in prevalence and risk factors of chronic kidney disease. Nephrol Dial Transplant2010; 25: 2564–2570.
14.
FoongAWPSawSMLooJL. Rationale and methodology for a population-based study of eye diseases in Malay people: The Singapore Malay Eye Study (SiMES). Ophthalmic Epidemiol2007; 14: 25–35.
15.
HughesKYeoPPLunKC. Cardiovascular diseases in Chinese, Malays, and Indians in Singapore. II. Differences in risk factor levels. J Epidemiol Community Health1990; 44: 29–35.
16.
CutterJTanBYChewSK. Levels of cardiovascular disease risk factors in Singapore following a national intervention programme. Bull World Health Organ2001; 79: 908–915.
17.
HughesKAwTCKuperanP. Central obesity, insulin resistance, syndrome X, lipoprotein(a), and cardiovascular risk in Indians, Malays, and Chinese in Singapore. J Epidemiol Community Health1997; 51: 394–399.
18.
TanCEEmmanuelSCTanBY. Prevalence of diabetes and ethnic differences in cardiovascular risk factors. The 1992 Singapore National Health Survey. Diabetes Care1999; 22: 241–247.
19.
LeveyASStevensLASchmidCH. A new equation to estimate glomerular filtration rate. Ann Intern Med2009; 150: 604–612.
20.
MatsushitaKMahmoodiBKWoodwardM. Comparison of risk prediction using the CKD-EPI equation and the MDRD study equation for estimated glomerular filtration rate. JAMA2012; 307: 1941–1951.
21.
TeoBWXuHKohYY. Estimating kidney function in a multiethnic Asian population with multiple filtration markers. Am J Kidney Dis2012; 60: 500–502.
22.
Singapore Myocardial Infarction Registry Report No. 1: Trends in Acute Myocardial Infarction in Singapore 2007–2010. National Registry of Diseases Office. Ministry of Health, Singapore.
23.
Annual Stroke Registry Report: Stroke Trends in Singapore 2005–2010. National Registry of Diseases Office. Ministry of Health, Singapore.
24.
National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification and stratification. Am J Kidney Dis2002; 39: S1–S266.
25.
HemmelgarnBRMannsBJLloydA. Relation between kidney function, proteinuria, and adverse outcomes. JAMA2010; 303: 423–429.
26.
LeveyASde JongPECoreshJ. The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report. Kidney Int2011; 80: 17–28.
27.
OhsawaMTannoKItaiK. Comparison of predictability of future cardiovascular events between chronic kidney disease (CKD) stage based on CKD epidemiology collaboration equation and that based on modification of diet in renal disease equation in the Japanese general population – Iwate KENCO Study. Circ J2013; 77: 1315–1325.
28.
KaysenGAEiserichJP. The role of oxidative stress-altered lipoprotein structure and function and microinflammation on cardiovascular risk in patients with minor renal dysfunction. J Am Soc Nephrol2004; 15: 538–548.
29.
HallanSIRitzELydersenS. Combining GFR and albuminuria to classify CKD improves prediction of ESRD. J Am Soc Nephrol2009; 20: 1069–1077.
30.
Chronic Kidney Disease Prognosis Consortium: Matsushita K, van der Velde M, Astor BC, et al. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet 2010; 375: 2073–2081.
31.
Brantsma AH1BakkerSJHillegeHL. Cardiovascular and renal outcome in subjects with K/DOQI stage 1–3 chronic kidney disease: the importance of urinary albumin excretion. Nephrol Dial Transplant2008; 23: 3851–3858.
32.
Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int Suppl2013; 3: 1–150.
33.
GrahamIAtarDBorch-JohnsenK. European guidelines on cardiovascular disease prevention in clinical practice: Fourth Joint Task Force of the European Society of Cardiology and other societies. Eur J Cardiovasc Prev Rehabil2007; 14: S1–S113.
34.
WeinerDETabatabaiSTighiouartH. Cardiovascular outcomes and all-cause mortality: exploring the interaction between CKD and cardiovascular disease. Am J Kidney Dis2006; 48: 392–401.
35.
Yahalom G1, Kivity S, Segev S, et al. Estimated glomerular filtration rate in a population with normal to mildly reduced renal function as predictor of cardiovascular disease. Eur J Prev Cardiol. Epub ahead of print 4 February 2013. DOI: 10.1177/2047487313476963.
36.
NakayamaMSatoTMiyazakiM. Increased risk of cardiovascular events and mortality among non-diabetic chronic kidney disease patients with hypertensive nephropathy: the Gonryo study. Hypertens Res2011; 34: 1106–1110.
37.
RoncoCHouseAAHaapioM. Cardiorenal syndrome: refining the definition of a complex symbiosis gone wrong. Intensive Care Med2008; 34: 957–962.
38.
PerkJDe BackerGGohlkeH. European Guidelines on cardiovascular disease prevention in clinical practice (version 2012): the Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. Eur J Prev Cardiol2012; 19: 585–667.
39.
Blood Pressure Lowering Treatment Trialists' Collaboration: Ninomiya T, Perkovic V, Turnbull F, et al. Blood pressure lowering and major cardiovascular events in people with and without chronic kidney disease: meta-analysis of randomised controlled trials. BMJ 2013; 347: f5680.
40.
ChobanianAVBakrisGLBlackHR. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension2003; 42: 1206–1252.
41.
Third Report of the National Cholesterol Education Program (NCEP). Expert panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults final report. Circulation2002; 106: 3143–3421.
